180 Life Sciences bets $425m on Ethereum treasury in bid to become ETHZilla
Palo Alto’s 180 Life Sciences is making a radical pivot, ditching biotech for crypto. With a $425 million private placement…
Palo Alto’s 180 Life Sciences is making a radical pivot, ditching biotech for crypto. With a $425 million private placement…